Paid Clinical Trials Colorado
Discover 1,160 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
LetrozoleLetrozole in Uterine Leiomyosarcoma
Sponsor:
GOG Foundation
Location:
Code:
NCT05649956
Conditions
Uterine Leiomyosarcoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Letrozole
DiamydA Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Sponsor:
Diamyd Medical AB
Location:
Code:
NCT05018585
Conditions
Type 1 Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 12 - 28
Healthy Volunteers: Not accepted
Interventions
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Colecalciferol 2000 IU
Placebo
Werewolf Flow 50Werewolf Flow 50 During ACL Reconstruction
Sponsor:
Children's Hospital Colorado
Location:
Code:
NCT04998656
Conditions
Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Rupture
Anterior Cruciate Ligament Tear
Arthrofibrosis of Knee
Eligibility Criteria
Sex: All
Age: 12 - 18
Healthy Volunteers: Not accepted
Interventions
Werewolf FLOW 50
Control
Observational StudyCutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty
Sponsor:
Colorado Joint Replacement
Location:
Code:
NCT03849885
Conditions
Degenerative Osteoarthritis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Benzoyl peroxide gel
Observational StudyDysvascular Amputation Self-Management of Health
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT04083456
Conditions
Amputation
Diabetes Mellitus
Peripheral Artery Disease
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Walking Biobehavioral Intervention
Attention Control
BMS-986365 vs. Investigator's ChoiceA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Celgene
Location:
Code:
NCT06764485
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986365
Enzalutamide
Abiraterone
Docetaxel
Predinsone/Prednisolone
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Inspiratory Muscle Strength TrainingInspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise
Sponsor:
University of Colorado, Boulder
Location:
Code:
NCT05000515
Conditions
Aging
Blood Pressure
Endothelial Dysfunction
Hypertension
Eligibility Criteria
Sex: Female
Age: 50+
Healthy Volunteers: Accepted
Interventions
High-resistance inspiratory muscle strength training
Aerobic exercise